Briggs Morrison - Jun 6, 2023 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
Director
Signature
/s/ Richard Morris, as Attorney-in-Fact for Briggs Morrison
Stock symbol
CARM
Transactions as of
Jun 6, 2023
Transactions value $
$0
Form type
4
Date filed
6/8/2023, 06:11 PM
Previous filing
May 10, 2023
Next filing
Jun 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Stock Option (Right to Buy) Award $0 +38.7K $0.00 38.7K Jun 6, 2023 Common Stock 38.7K $7.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over three years in equal monthly installments following June 6, 2023, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.